AI Science Tracker
EN

Identification of WDR74 and TNFRSF12A as biomarkers for early osteoarthritis using machine learning and immunohistochemistry.

Department of Orthopedics; Institute of Microsurgery on Extremities · 28 Jan 2025 · medicine

Discovery

Identification of WDR74 and TNFRSF12A as biomarkers for early osteoarthritis using machine learning and immunohistochemistry.

Source check: Source checked. Not independent scientific confirmation.

Finding: XGBoost-selected WDR74 and TNFRSF12A differentiated osteoarthritis samples, with qPCR and human knee-tissue immunohistochemistry confirmation.

Technology: Single-cell and co-expression analyses feed XGBoost marker selection; the source reports diagnostic AUCs above 0.9 and laboratory/tissue checks.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Single-cell and co-expression analyses feed XGBoost marker selection; the source reports diagnostic AUCs above 0.9 and laboratory/tissue checks.
Test and result
Human tissue IHC and in-vitro qPCR support expression differences; no prospective screening benefit is claimed.
Limitation / still unknown
Primary Results describe the specific comparator, cohort or experimental check; limitations are stated narrowly.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1517646/full · https://europepmc.org/article/MED/39935469 · https://pubmed.ncbi.nlm.nih.gov/39935469/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.